Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans.
about
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapyA review of omega-3 ethyl esters for cardiovascular prevention and treatment of increased blood triglyceride levelsBioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects--a randomized, single-dose, cross-over trialResolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets.Fruitflow®: the first European Food Safety Authority-approved natural cardio-protective functional ingredient.Altered essential fatty acid metabolism and composition in rat liver, plasma, heart and brain after microalgal DHA addition to the diet.A protective lipidomic biosignature associated with a balanced omega-6/omega-3 ratio in fat-1 transgenic miceVitamin E-deficient diets enriched with fish oil suppress lethal Plasmodium yoelii infections in athymic and scid/bg mice.Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activityLipids, atherosclerosis, and restenosis after percutaneous transluminal coronary angioplastyOmega-3 Index and sudden cardiac death.Pharmacokinetics of Eicosapentaenoic Acid in Plasma and Red Blood Cells After Multiple Oral Dosing With Icosapent Ethyl in Healthy Subjects.Dietary n-3 fatty acid effects on neutrophil lipid composition and mediator production. Influence of duration and dosage.Fish oils--adjuvant therapy in chronic heart failure?Omega-3 Fatty Acid Ethyl Esters do not Improve Clopidogrel Associated P2Y12 Inhibition in Stroke PatientsThe Pharmacokinetic Profile of a New Gastroresistant Capsule Preparation of Eicosapentaenoic Acid as the Free Fatty Acid.Red Blood Cell Docosapentaenoic Acid (DPA n-3) is Inversely Associated with Triglycerides and C-reactive Protein (CRP) in Healthy Adults and Dose-Dependently Increases Following n-3 Fatty Acid Supplementation.Investigations of human platelet-type 12-lipoxygenase: role of lipoxygenase products in platelet activation.The effect of omega-3 fatty-acid supplements on perioperative bleeding following posterior spinal arthrodesisLower eicosapentaenoic acid and higher arachidonic acid levels in Sera of young adults in the Netherlands than in Japan.Effects of combination treatment with policosanol and omega-3 fatty acids on platelet aggregation: A randomized, double-blind clinical study.The differential effects of EPA and DHA on cardiovascular risk factors.Omega-3 polyunsaturated fatty acids and cancer: lessons learned from clinical trials.Polyunsaturated fatty acid metabolism in enterocyte models: T84 cell line vs. Caco-2 cell line.Metabolic fate of docosahexaenoic acid (DHA; 22:6n-3) in human cells: direct retroconversion of DHA to eicosapentaenoic acid (20:5n-3) dominates over elongation to tetracosahexaenoic acid (24:6n-3).Invited comment: notes on alternate lipids to omega-PUFA.Intravenous infusion of tridocosahexaenoyl-glycerol emulsion into rabbits. Effects on leukotriene B4/5 production and fatty acid composition of plasma and leukocytes.The influence of a fish oil high in docosahexaenoic acid on plasma lipoprotein and vitamin E concentrations and haemostatic function in healthy male volunteers.Differential effects of omega-3 fish oils on protein kinase activities in vitro.Veterinary nutraceutical medicine.A butter diet induces higher levels of n-3 PUFA and of n-3/n-6 PUFA ratio in rat serum and hearts than a safflower oil diet.Dietary DHA: time course of tissue uptake and effects on cytokine secretion in mice.Use of red blood cell fatty-acid profiles as biomarkers in cardiac disease.Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index.Polyunsaturated fatty acid pattern and fish oil treatment in inflammatory bowel disease.Eicosapentaenoic and docosahexaenoic acid supplementations reduce platelet aggregation and hemostatic markers differentially in men and women.Effect of purified eicosapentaenoic acid on red cell distribution width in patients with ischemic heart disease.Effects of four doses of n-3 fatty acids given to hyperlipidemic patients for six months.The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review.Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters.
P2860
Q24675327-DAB29CBB-691F-402E-BE00-DE25627FB091Q28219488-10890338-2D75-469A-942E-EFCC55EE909AQ28260672-651859B4-6DB5-4330-82F5-E2FAA685852CQ30482801-5F21342D-FEBE-45DC-B58F-D593B13A6818Q34533314-6650FEA9-7460-44DF-B18E-5919C34CCE5DQ34785849-628E699F-EF37-4BCB-A5DA-8BA371B86921Q35156337-E78F5F24-9969-405D-8A08-38D37D7CC8FDQ35533780-700759B1-CB18-4ADE-8D3A-72917B3708D0Q35536831-88401AEE-EE49-4365-B633-ADDB03DC2AC6Q35647750-4AE5AC98-2F1B-4D0C-B666-6979129662F1Q35670915-75E02DE4-8099-48B4-9C45-AA47AE19CD2CQ35741991-4ED107C2-303F-4ECA-8BF1-2E58D69DA781Q35823788-8B252D4C-7291-4AEE-9B87-D1511270E859Q35855345-29451932-23C4-48E2-B1D5-636E2059A71FQ35868946-6670AB9B-F45F-40FE-AFB9-187990451CC2Q35960415-1D0E7109-9EC2-4217-8FE7-6BACEB498750Q36012382-0E38D209-7F5F-4975-8766-535779353396Q36387226-36584E76-579C-422E-8CC4-AD9B59F75E31Q36428599-8FE4FC9F-BAE4-401C-9B58-1CEF32991535Q37296487-9EBDCEB0-8954-4E78-A94F-3463CCAA8B20Q37663465-0ABDE868-AB38-478A-9822-F4C6B1D5182AQ37846894-97D2EF25-BF43-402F-98BB-AC1AB278254DQ38557891-6E29A87A-455B-40BF-A3D5-53C9A9A8C592Q39104037-EB0012DF-C635-44E3-B6A1-2626DCB6E7EFQ39471285-305AC5CA-BB6F-4E89-8495-74E83320EE99Q39555606-6E7F0254-FDAA-416E-9C55-C9D1ACC2E1A1Q40304874-6FC8C90A-FB4C-441F-B469-85E45C4BCCFCQ41114309-5A287327-B6AB-439E-8E50-881459A68172Q41996645-4E3E6435-B5BD-451E-843A-2F148D9456AAQ42062393-1896E6D1-86F0-433F-BAC9-065A504AACB1Q42745043-62D224D0-AA06-4AF2-94A9-249FB2845794Q43058332-FB27E4A8-1E0A-4031-ABC1-2A24A816A0E2Q43061596-2C847F28-5E91-4247-8B3B-36E43421E94BQ43085164-195B0D1A-9E48-4D83-AF5D-B94818030421Q43214835-023899B5-CAA1-4628-9781-E9FFAA1E9E0BQ43961943-D8AE22B9-C4FB-4E21-BB5E-84C73C3ED58AQ44849262-7E93E396-24B0-45A2-B3A4-F83C153AE8E0Q45122725-B30459DF-8E96-4D87-BACC-3F96F6759BEBQ50099570-2AEE1841-DF9A-4F0B-B4A8-C1FE961E9924Q50555472-3B0A9290-C352-4199-9D38-276AE6809FDC
P2860
Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Metabolism and effects on plat ...... cosahexaenoic acids in humans.
@en
type
label
Metabolism and effects on plat ...... cosahexaenoic acids in humans.
@en
prefLabel
Metabolism and effects on plat ...... cosahexaenoic acids in humans.
@en
P2860
P356
P1476
Metabolism and effects on plat ...... cosahexaenoic acids in humans.
@en
P2093
von Schacky C
P2860
P304
P356
10.1172/JCI112261
P407
P577
1985-12-01T00:00:00Z